drugset / Trial / NCT00014066

Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer

NCT00014066

Phase 1 Completed Roswell Park Cancer Institute
Treatment

Summary

RATIONALE: Photodynamic therapy uses light and drugs that make cnacer cells more sensitive to light to kill tumor cells. Brachytherapy uses radiation to damage tumor cells. Photodynamic therapy combined with brachytherapy may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of photodynamic therapy plus brachytherapy in treating patients with recurrent lung cancer that is blocking the lung passages.

Timeline

Start
1993-03
Primary completion
2004-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule Other

Indications